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Background: The quantification of pain intensity in vivo is essential for identifying the mechanisms of various types
of pain or for evaluating the effects of different analgesics. A variety of behavioral tests for pain measurement have
been devised, but many are limited because animals are physically restricted, which affects pain sensation. In this
study, pain assessment was attempted with minimal physical restriction, and voluntary movements of unrestrained
animals were used to evaluate the intensities of various types of pain.
Results: The number of times animals reared or total distances traveled was measured using a motion-tracking
device and found to be markedly reduced in carrageenan-induced inflammatory, acetic acid-induced visceral, and
streptozotocin-induced neuropathic pain tests. These two voluntary movement parameters were found to be highly
correlated with paw withdrawal latency from irradiating heat. In addition, these parameters were markedly reversed
by morphine and by non-steroidal anti-inflammatory drugs in inflammatory pain models. These parameters were
also useful to detect hypoalgesia in TRPV1−/− mice.
Conclusions: These results suggest that parameters of voluntary movement, such as, number of rearing and total
distance moved, are effective indicators of pain intensity for many types of pain and that they can be used to
evaluate degree of pain perception.
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TRPV1Background
Pain is an unpleasant sensation that warns of tissue
damage, whether caused physically or chemically, and
thus, the ability to detect pain is essential for protection
and survival [1-3]. Whereas acute pain is evoked by
damaging or intense stimuli, chronic pain is associated
with injury and diseases [4,5]. Because chronic diseases,
such as cancer, often accompany with severe pain, study
of the pain mechanisms is essential to develop cures for
chronic pain [6]. Because pain is a subjective, emotional,
and pseudo-affective sensation, the estimation of pain
intensity is substantially affected by emotional state.
Many different types of pain measuring methods have
been devised to measure pain-related behaviors elicited* Correspondence: utoh@snu.ac.kr
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reproduction in any medium, provided the orin animals to various insults [7-9]. These tests are largely
based on the reflex responses of animals evoked by nox-
ious or non-noxious stimuli. Common reflexive tests
used to assess inflammatory or neuropathic pain are
hot-plate, tail-flick, Hargreaves, Von Frey hair, and
Randal Selitto tests [8-11]. These tests are useful tools in
pain research and have been used widely. However, they
may have some limitations. Specifically, in order to
evoke reflex responses, various types of noxious or non-
noxious stimuli need to be imposed on legs, tails or
other parts of the body. Furthermore, free movement of
an animal is somewhat restricted or placed in a small
cage to deliver noxious stimuli. The need for physical re-
striction, by holding the trunk or legs or confining an
animal to a small case, evidently creates stress, which is
likely to affect pain sensitivity. In addition, reflex-based
pain tests are also limited by their subjective nature of
measurements. Measurement of withdrawals of tails or
legs from noxious stimuli is sometimes ambiguous.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cumvents these limitations.
In this study, we examined whether parameters based
on voluntary movements could be used to assess pain
severity objectively in specific pain models. We reasoned
that unconfined mice or rats move freely and sometimes
stand on their hind legs to explore their environments,
but that animals in pain would be reluctant to move.
Methods
Animals
This study was performed in accordance with protocols
approved by the Committee on Laboratory Animals at
the Seoul National University. Experiments were also
conducted according to the Ethical Guidelines of the
International Association for the Study of Pain. Adult
male Sprague–Dawley rats (180–230 g), wild type
C57Bl/6J mice (18 – 23 g) (Koatech, Seoul), and TRPV1
deficient C57Bl/6J mice (Jackson Laboratory, Bar
Harbor, ME) were used for the behavioral tests. All
experiments were performed during the day time (9:00
a.m. and 6:00 p.m.). Animals for all experiments were
habituated before testing.
Carrageenan- induced inflammation
To induce inflammation, carrageenan (2%) was injected
subcutaneously into both plantar surfaces of the hind
paws of rats and mice (40 μl in rats and 20 μl in mice).
For control experiment, 40 or 20 μl of saline were
injected subcutaneously into both plantar surfaces of the
hind paws of rats or mice.
Drug treatment
Morphine (2 mg/kg or 10 mg/kg), ibuprofen (20 mg/kg)
or diclofenac (10 mg/kg) were administered intraperito-
neally (i.p.) 20 or 30 min or 1 hr before voluntary behav-
ioral testing, respectively. Acetic acid (10 mg/kg; i.p.) or
celecoxib (10 mg/kg; p.o.) were also administered to
mice 15 min or 1 hr before voluntary behavioral test. All
nonsteroidal anti-inflammatory drugs were purchased
from Sigma-Aldrich and dissolved in physiological sa-
line, with the exception of celecoxib that was suspended
in 1% methylcellulose plus 0.1% tween80.
Spared nerve injury (SNI) model
Spared nerve injury was performed as previously de-
scribed [12]. Briefly, mice were anesthetized by intraperi-
toneal injection of 50 mg/kg pentobarbital. We checked
reflexes by pinching the paws using a pincette. Then, we
used scissors to make a 1 cm incision in the longitudinal
direction around the knee. Injury was induced in mice
through cutting tibial and common peroneal nerve
branches among three branches of the sciatic nerve.Same surgical procedure was performed in sham control,
except that the sciatic nerve remained undisturbed.
Streptozotocin-induced diabetes
Diabetes was induced in mice by administering strepto-
zotocin (STZ) (150 mg/kg; i.p.). Plasma glucose levels were
measured using a glucose test kit (LIFESCAN, Milpitas,
CA) in blood samples obtained from a tail vein.
Measurement of voluntary movements
An unrestrained mouse or rat was placed in a 43 cm × 43
cm activity cage and the number of rearings and the total
distance traveled were measured using a fully automated,
photocell-based system (ATM3 Auto-Track system,
Columbus Instruments, Columbus, OH). This system in-
volves multiple Opto-Varimex Animal activity monitors
that are connected to a computer. The location of an ani-
mal in the horizontal plane (used to calculate the distance
travelled) and number of beam breaks in the vertical plane
(indicative of rearing), as determined by the Opto-
Varimex optical tracking system, were transmitted to a
computer using the Columbus Instruments Bus system.
Horizontal activity was detected using 15 photo sensors
on the front and back walls and 15 photo sensors on both
side walls of the activity cage. Numbers of rearings were
determined using 15 side wall sensors located 13 cm above
the cage floor for rats and 6 cm for mice.
Hargreaves plantar test
This test was performed using a standard apparatus
(Ugo Basile Biological research Apparatus) as previously
described [8]. Briefly, a rat was placed in a transparent
acrylic box and infrared heat lamp was positioned
underneath the targeted hind paw. A radiant stimulus
was then applied to the plantar surface and paw with-
drawal latency was measured.
von Frey test
Mechanical allodynia was measured by prodding the
plantar region of hindpaw with calibrated von Frey fila-
ments (Stoelting Co., Wood Dale, IL). Animals were
placed in cages with a mesh grid floor. On testing day,
mice were allowed to acclimate for a minimum of 30
min before experiment. Plantar surface of hind foot was
poked with von Frey filaments of different thickness.
Withdrawal thresholds to von Frey filaments were deter-
mined when animals lifted a hindpaw at least 5 re-
sponses out of 10 stimulations. Minimum weight of the
von Frey filament that evoked response was considered
as a mechanical withdrawal threshold.
Rotarod test
Animals were pre-trained on an automated 4-lane
rotarod unit (Ugo basile, Italy) for 3 days before being
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to improve grip. An accelerating protocol was used.
Briefly, a rat was placed on the rod, which was accel-
erated smoothly from 0 to 35 rpm over 3 minutes.
Times on the rod were measured automatically by
placing a trip switch under the floor beneath the ro-
tating drum.
Writhing test
Mice were injected with 10 ml/kg of 0.7% acetic acid
i.p. and placed in an activity cage for observation.Figure 1 Measurement of voluntary movement in a carrageenan-indu
saline was injected subcutaneously (s.c.) into the plantar surfaces of both h
was measured (n = 5–10, ***p<0.001) at 2h, 3h, 4h after carrageenan inject
measured at 2h, 3h, and 4h after carrageenan or saline injection for 20 min
number of rearings and withdrawal latencies to noxious thermal stimuli in
= 0.92). (B) A trace of rat movements over 20 min after administering salin
min were measured at 2h, 3h, and 4h after carrageenan or saline injection
withdrawal latency to noxious thermal stimuli was performed in rats 2h, 3hNumbers of writhes (defined as a contraction of the
abdomen followed by twisting and turning of the
trunk, and extension of hind limbs) were counted for
20 min.Statistics
All results are expressed as means ± SEMs, and were an-
alyzed by one-way analysis of variance (ANOVA)
followed by Tukey’s post-hoc test. Statistical significance
was accepted for p values of < 0.05.ced inflammatory pain model. (A) Left, Carrageenan (2% in 40 μl) or
indpaws in rats. Latency of withdrawal response to a thermal stimulus
ion. Results are means ± SEMs. Middle, Number of rearings were
(n = 7–9). Right, Pearson correlation analysis of the relation between
rats at 2h, 3h, and 4h after carrageenan injection (n = 5–9, *p<0.05, r2
e (CTL) (left) or carrageenan (Carr). (C) Total distances moved over 20
(n = 7–9). The correlation between total distance moved and
, and 4h after carrageenan injection (n = 5–9, r2 = 0.9).
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Parameters of voluntary movement decrease during
inflammation
To evaluate voluntary movements in relation to pain,
rats were placed in the activity chamber and total dis-
tances travelled and number of rearings, which were
considered a behavior related to curiosity or exploration
[13,14], were recorded automatically (Figure 1). When
saline-treated rats were placed in the activity chamber,
they moved in a normal manner. Numbers of rearings
and total distances moved in the activity cage over 20
min were counted and compared with the parameters
measured using conventional reflexive pain tests.
First, Hargreaves test results and rearing behavior were
compared using an inflammatory pain model. To induce
inflammation, carrageenan (2% w/v, 40 μl; s.c.) wasFigure 2 The effects of nonsteroidal anti-inflammatory drugs on volu
rearings and the total distances moved over 20 min were measured at 4 h
numbers of rearing or total distances relative to their control values. Ibupro
before test (n = 7–8). (B) Numbers of rearings and the total distances move
Diclofenac (10 mg/kg) and saline were administrated i.p. into rats 1hr befo
moved over 20 min were measured at 4 h after carrageenan injection. Cele
test (n = 7–8). (D-E) The effects of ibuprofen and diclofenac (D) and celeco
with of ibuprofen (20 mg/kg), diclofenac (10 mg/kg), celecoxib (10 mg/kg)injected into the plantar surfaces of both hind paws of
rats. For control experiment, physiological saline was ad-
ministered into the plantar surfaces of both hind paws
of rats. Withdrawal latency from radiant heat was mea-
sured 2, 3, and 4 hours after carrageenan or saline ad-
ministration. As time passed, control group failed to
show change in withdrawal latency. However, the with-
drawal latencies of carrageenan-treated rats became sig-
nificantly shorter than the latency before carrageenan
administration (Figure 1A) with paw swelling and red-
ness (data not shown). To obtain voluntary movement
results, rats were placed in the activity chamber, and ver-
tical and horizontal motions were recorded for 20 min
at 2, 3, and 4 hours after carrageenan administration. As
shown in Figure 1A, a marked time-dependent reduction
in rearing behavior was observed, and this was found tontary movements in carrageenan-injected rats. (A) Numbers of
after carrageenan injection. Data represent the percentage of the
fen (20 mg/kg) and vehicle were administrated i.p. into rats 30 min
d over 20 min were measured at 4 h after carrageenan injection.
re test (n = 7–8). (C) Numbers of rearings and the total distances
coxib (10 mg/kg) and saline were administrated p.o. into rats before
xib (E) on motor function. Rotarod test was examined in rats treated
, or vehicle. Time on the beam was recorded as latency (n = 7–9).
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latency (Figure 1A, r2 = 0.92, n = 5–9).
The total distances moved by saline- and carrageenan
administered rats were also evaluated. Figure 1B shows
representative traces of saline- and carrageenan-treated
rats free to explore the activity cage. The total distances
moved over 20 min by carrageenan-treated rats 3 and 4
hours after carrageenan-injection were significantly
lower than those of saline-treated rats (Figure 1C, n =
7–9). Total distances moved were also found to be
highly correlated with paw withdrawal latencies deter-
mined by the Hargreaves test by linear regression
(Figure 1C, r2 = 0.9, n = 5–9).
Effects of nonsteroidal anti-inflammatory drugs on
voluntary movements
We then determined whether nonsteroidal anti-inflam-
matory drugs (NSAIDs) used commonly to treat inflam-
matory pain could recover the reduction of voluntary
movements during inflammation. Ibuprofen (20 mg/kg)
and diclofenac (10 mg/kg), non-selective cyclooxygenase
inhibitors were injected intraperitoneally to carrageenan
administered rats 30 min and 1 hr before measuring vol-
untary movements (4 hours after carrageenan adminis-
tration). As shown in Figure 2A, ibuprofen-treated and
carrageenan-injected rats moved as freely as treatment
naïve rats. In contrast, saline treated and carrageenan-
injected rats failed to move as vigorously as treatment
naïve controls. Thus, reductions in total distance moved
and numbers of rearings by carrageenan-induced
inflammation were completely reversed by ibuprofen
(Figure 2A). Diclofenac-treated and carrageenan-injected
rats also recovered decrease of numbers of rearings
and total distance moved induced by inflammation
(Figure 2B). Next, we tested that the effect of a selective
cyclooxygenase type 2 inhibitor, celecoxib on carra-
geenan injected-mice. As shown in Figure 2C, celecoxibFigure 3 The effects of morphine on voluntary movements in carrage
after carrageenan injection. Morphine was administered i.p. at 2 or 10 mg/
min were measured 4h after carrageenan injection and 10 min after admin
morphine on motor coordination was examined using the rotarod test in r
recorded as latencies (n = 5–7).(10 mg/kg, p.o.) and carrageenan treated mice signifi-
cantly recovered the decrease of voluntary movements
compared to vehicle and carrageenan treated mice. The
reduction in voluntary movements was not due to the
reduction in motor coordination because the NSAIDs-
treated rats failed to exhibit a difference in time staying
on rotating rod compared to saline or vehicle injected
rats (Figure 2D, E).
Effects of morphine on voluntary movements
Morphine administered to rats at 2 mg/kg (i.v.) signifi-
cantly increased numbers of rearings and total distance
moved versus carrageenan-injected rats (Figure 3A, B).
However, when a maximum dose of morphine
(10 mg/kg) was administered, the reduction in numbers
of rearings and total distances was greater than after ad-
ministering morphine at 2 mg/kg, suggesting a possible
sedative effect. In fact, it has been well documented that
a morphine dose greater than 5 mg/kg causes sedation
[14,15]. Indeed, when rats administered 10 mg/kg mor-
phine stayed on the rotating rod for less time than rats
administered 2 mg/kg (140.9 ± 17.3 vs 61.6 ± 11.9 sec, p
< 0.05, n = 5–7, Figure 3C), indicating a reduction in
motor coordination or balance. This effect of sedation
was not detected by conventional reflexive pain tests.
Voluntary movements in mice with acute visceral pain
We now tested whether voluntary movements would
also represent the acute pain state. To do so, we used an
acute visceral pain model [16-18]. The administration of
dilute acetic acid (0.7%; i.p.) produced a writhing re-
sponse in mice. Acetic acid treated mice showed a ro-
bust writhing response as compared with saline treated
mice (81 ± 11.9 vs 2.2 ± 0.9, p < 0.001, n = 6, Figure 4).
In contrast to writhing behavior, numbers of rearings
(91.6 ± 18.8 vs 24.5 ± 1.5, p < 0.01, n = 6) and total
distances moved (3291.6 ± 411.4 vs 2121.5 ± 211.9,enan-injected rats. (A) Numbers of rearings were measured at 4h
kg 10 min before testing (n = 7–8). (B) Total distances moved over 20
istering morphine (2 or 10 mg/kg, i.p.) (n = 7–8). (C) The effect of
ats treated with 2 or 10 mg/kg of morphine. Times on the beam were
Figure 4 Voluntary movements of mice with acute visceral pain induced by acetic acid. (A) Acetic acid was administered at 10 mg/kg
intraperitoneally. Numbers of writhes were measured over 20 min after the injection of saline or acetic acid (n = 6). (B-C) Voluntary movements
were measured in saline or acetic acid treated mice. Acetic acid treated mice showed a significant reduction in number of rearings. (B) and total
distance moved (C) (n = 6).
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treated mice (Figure 4B and C). These results suggest
that reduction of voluntary movements represent acute
pain.
Voluntary movements of diabetic neuropathic mice
We then attempted to determine whether voluntary
movements are correlated with neuropathic pain using a
diabetic neuropathic pain model [19,20]. A single dose
of streptozotocin (STZ) (150 mg/kg; i.p.) was used toFigure 5 Voluntary movements of streptozotocin-induced diabetic m
(STZ) to induce diabetes. Glucose levels were measured at 4 weeks after in
Withdrawal thresholds to von Frey hair filaments of vehicle or STZ treated
mice. STZ treated mice showed a significant reduction in the number of reinduce diabetes. Four weeks after STZ treatment, a four-
fold increase in the blood glucose level (145.7 ± 5.7 vs
491.3 ± 14.2 mg/dl blood, p < 0.001, n = 7–11) was
observed in the STZ-treated mice (Figure 5A). To
observe the time-dependent change of mechanical
hypersensitivity for 4 week period, von Frey test was
performed on every week in vehicle and STZ treated
mice. Mechanical withdrawal threshold of STZ-treated
mice was significantly reduced in 4 week after adminis-
tration of STZ (Figure 5B). As was expected, diabeticice. (A) Blood glucose levels of mice administered with streptozotocin
jecting vehicle or STZ (150 mg/kg i.p.) in mice (n = 7–11). (B)
mice (n = 7–11). (C-D) Voluntary movements in vehicle or STZ treated
arings (C) and in total distances moved (D) (n = 7–11).
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movements (Figure 5C and D).
Voluntary movements in spared nerve injury induced
mice
Next, we examined whether voluntary movements could
be applied to evaluate another type of neuropathic pain
model, spared nerve injury (SNI) model [12]. SNI was
induced by a surgical procedure that cut 2 out of 3
branches of the sciatic nerve of a rat (see Methods).
Mechanical allodynia was measured in sham-operated
and SNI groups at 1 week and 4 week after surgery
(Figure 6). At 1 week after surgery, the SNI group
resulted in a significant decrease in mechanical with-
drawal threshold compared to the sham control group
(0.65 ± 0.19 vs 0.23± 0.09g, p < 0.05, n = 9–10). The re-
duction in mechanical threshold was still observed in
the SNI group at 4 week after surgery (0.66 ± 0.13 vs
0.21 ± 0.08g, p < 0.05, n = 9–10). In contrast, the num-
ber of rearing and the total distance moved of the SNI
group rats were not different from those of the sham
control group at 1 week or 4 week after surgery. These
results indicate that the voluntary movements do not
represent some types of chronic pain such as a SNI
neuropathic model.
Voluntary movements in mice lacking TRPV1
Next, we then applied the voluntary movement parame-
ters to a genetically deficient-mice model. TRPV1 isFigure 6 Voluntary movements in mice with spared nerve injury (SNI
hair filaments in mice at 1 week (top) or 4 week (bottom) after surgery on s
(B-C) Numbers of rearings (B) and total distances moved (C) over 40 min w
control groups (n = 9–10).highly expressed in nociceptors and activated by capsa-
icin, heat and other endogenous lipids [1,21,22]. Al-
though mice lacking TRPV1 elicit reduced inflammatory
thermal hyperalgesia when tested with reflexive pain test
models [23,24], it is not known whether TRPV1−/− mice
show reduced pain behavior when tested with non-
reflexive pain tests. Therefore, we examined whether
TRPV1−/− mice would show change in voluntary move-
ments as much as that of the wild-type mice. Before car-
rageenan was administered, wild-type and TRPV1−/−
mice showed similar voluntary movements, such as
rearings and total distance travelled. However, when in-
flammation developed at 4 hrs after carrageenan injec-
tion, wild-type mice showed a marked reduction in
rearings and total distance travelled, whereas the reduc-
tions in rearings and total distance travelled of TRPV1
−/− mice were significantly less than those of the wild-
type mice (Figure 7A and B). Thus, parameters in volun-
tary movement can be useful to determine pain severity
in genetically-modified mice.
Discussion
In the present study, we examined the use of number of
rearings and total distance moved as measures of pain,
and compared the results obtained with those of reflex-
based pain tests. Both parameters were found to be associ-
ated with pain intensity because they decreased in-line
with paw-withdrawal latency from radiant heat in the
carrageenan-induced inflammatory pain model, and in-)-induced neuropathic pain. (A) Withdrawal thresholds to von Frey
ciatic nerves (SNI group) or sham operated control group (n = 9–10).
ere measured at 1 week or 4 week after surgery (SNI group) or sham
Figure 7 The contribution of TRPV1 to voluntary movements in
a carrageenan-induced pain model. (A) Numbers of rearings over
40 min were measured at 4 h after saline (CTL) or carrageenan (Carr)
injection in wild type mice and TRPV1 KO mice (n = 4–8). (B) Total
distances moved over 40 min were measured at 4 h after saline
(CTL) or carrageenan (Carr) injection in wild type mice and TRPV1
KO mice (n = 8 – 10).
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Frey filaments in a neuropathic pain model. More import-
antly, reductions in both parameters were reversed by
NSAIDs and morphine. These results suggest that these
two parameters could be used to evaluate pain intensity.
Most of pain tests are based on reflexes evoked by
various noxious or non-noxious stimuli. These reflex-
based pain tests have been widely used as tools for pain
measurements in pre-clinical study. Although these
reflex-based pain tests are useful to determine intensities
of various types of pain, these pain tests may have some
limitations, especially for evaluating complex and sub-
jective pain states of patients [25]. Many approaches
have been made to develop non-reflexive pain measure-
ments. For example, Matson and colleagues suggested
that reduction in the number of rearing may indicate in-
flammatory pain in knee joints [26]. Peripheral inflam-
mation reduces voluntary wheel running or voluntary
movements in mice or rats [27,28]. Hypolocomotion
after knee surgery has been used to evaluate postopera-
tive pain [29]. In line with these reports, the present
study further supports the eligibility of voluntary move-
ment as a useful tool for pain intensity assessment.
However, in some chronic pain models, mechanical
hypersensitivity does not match with hypolocomotion
[30]. For example, mechanical hyperalgesia induced by
SNI lasts for several weeks, whereas locomotion is not
different between injured and naïve animals [30]. In ac-
cordance with this, in this study, number of rearing and
total distance moved in SNI group were not different
from those of shame control group. Interestingly, volun-
tary movements of mice with chronic constriction injury
on sciatic nerve are reduced [30]. Moreover, diabetic
neuropathic pain model in this study showed a signifi-
cant reduction in voluntary movements as well as mech-
anical threshold (Figure 5). Thus, voluntary movements
may represent some types of pain, not all types of
chronic pain.Another concern regarding use of non-reflexive pain
tests is the location of injury. If the injury is given to
lower limbs, it seems difficult to judge whether the re-
duction in voluntary movement is caused by the diffi-
culty in physical motion or the reluctance of motion due
to perception of pain. To answer this question, we applied
noxious stimulus, acetic acid, to peritoneum. The acetic
acid-treated mice exhibited reduced voluntary movements
(Figure 3). Thus, change in voluntary movement may rep-
resent the intensity of various types of pain.
The merits of using voluntary movements to assess
pain are many folds. First, because animals are placed in
a relatively large chamber they are able to move freely
without physical restriction, which avoids the stress
caused by restricting holding animals, which could affect
pain sensitivity [26,31]. Second, the testing is easily
performed and is less subjective than conventional
tests because measurements are recorded automatically.
Third, voluntary movements involve cerebral compo-
nents of pain perception and possibly exclude compo-
nents of spinal nociceptive reflexes. Fourth, the testing
does not need habituation because it utilizes the explora-
tory behavior. Finally, the testing covers various types of
pain models, such as acute as well as inflammatory and
neuropathic pain.
The present study also shows that observed reduc-
tions in voluntary movements were significantly
reversed by common analgesic drugs, such as ibupro-
fen, diclofenac, celecoxib and by morphine, which
indicates that measurements of voluntary movements
provide a means of evaluating the analgesic efficacies
of non-steroidal anti-inflammatory drugs or opiates.
Some analgesics cause sedation [32]. For example,
morphine is well known to act as a sedative at higher
doses [26,33,34], and therefore, it is important to
distinguish between analgesic and adverse cognitive
effects when evaluating analgesic activities. However,
classical pain tests often produce false-positive results
for drugs with a sedating effect, because analgesic
responses and sedative responses cause conventional
pain tests to move in the same direction. But this is
not the case for voluntary movement testing: an
increase in voluntary movement indicates an analgesic
effect whereas a decrease indicates a sedative
effect. Thus, the use of voluntary movement testing is
likely to reduce false-positive results for analgesics
[26,34].
Summarizing, voluntary movement measurements
were found to provide measured of some types of
chronic pain. We believe that application of this type
of testing during basic studies or screening candidate
drugs would contribute to our understanding of pain
mechanisms and thus to the development of new
analgesics.
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In summary, our results show that voluntary movements
are effective and easy measurements for evaluating in-
tensity for various types of pain. Therefore, they can be
useful tools for screening candidate chemicals for novel
analgesics.
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